Total: £ 56.28
Published Date: 2026-01-23 | Pages: 118 | Tables: 117 | Medical Care
The global Single Cancer Screening market was valued at US$ 1553 million in 2025 and is anticipated to reach US$ 3724 million by 2032, at a CAGR of 13.5% from 2026 to 2032.
Single cancer screening refers to screening procedures focused on a specific type of cancer, aimed at early detection to improve treatment outcomes and survival rates. This type of screening typically includes specific tests for certain cancers, such as mammography for breast cancer, Pap smears for cervical cancer, or blood tests for prostate cancer. The implementation of single cancer screening helps identify high-risk populations and provides timely interventions, effectively reducing cancer-related mortality.
The North American market for Single Cancer Screening is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Single Cancer Screening is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Single Cancer Screening in Hospital is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Single Cancer Screening include Grail, Exact Sciences, Oncognostic, Epigenomics, Abbott, Qiagen, iStat Biomedical, Genetron Health, New Horizon Health, Burning Rock, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Single Cancer Screening market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Single Cancer Screening. The Single Cancer Screening market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Single Cancer Screening market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Single Cancer Screening manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Grail
Exact Sciences
Oncognostic
Epigenomics
Abbott
Qiagen
iStat Biomedical
Genetron Health
New Horizon Health
Burning Rock
Berry Oncology
Shanghai Kunyuan Biotechnology
Segment by Type
Colorectal Cancer
Liver Cancer
Lung Cancer
Other
Segment by Application
Hospital
Physical Examination Center
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Single Cancer Screening companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Single Cancer Screening Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Colorectal Cancer
1.2.3 Liver Cancer
1.2.4 Lung Cancer
1.2.5 Other
1.3 Market by Application
1.3.1 Global Single Cancer Screening Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Physical Examination Center
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Single Cancer Screening Market Perspective (2021–2032)
2.2 Global Single Cancer Screening Growth Trends by Region
2.2.1 Global Single Cancer Screening Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Single Cancer Screening Historic Market Size by Region (2021–2026)
2.2.3 Single Cancer Screening Forecasted Market Size by Region (2027–2032)
2.3 Single Cancer Screening Market Dynamics
2.3.1 Single Cancer Screening Industry Trends
2.3.2 Single Cancer Screening Market Drivers
2.3.3 Single Cancer Screening Market Challenges
2.3.4 Single Cancer Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Single Cancer Screening Players by Revenue
3.1.1 Global Top Single Cancer Screening Players by Revenue (2021–2026)
3.1.2 Global Single Cancer Screening Revenue Market Share by Players (2021–2026)
3.2 Global Top Single Cancer Screening Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Single Cancer Screening Revenue
3.4 Global Single Cancer Screening Market Concentration Ratio
3.4.1 Global Single Cancer Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Single Cancer Screening Revenue in 2025
3.5 Global Key Players of Single Cancer Screening Head Offices and Areas Served
3.6 Global Key Players of Single Cancer Screening, Products and Applications
3.7 Global Key Players of Single Cancer Screening, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Single Cancer Screening Breakdown Data by Type
4.1 Global Single Cancer Screening Historic Market Size by Type (2021–2026)
4.2 Global Single Cancer Screening Forecasted Market Size by Type (2027–2032)
5 Single Cancer Screening Breakdown Data by Application
5.1 Global Single Cancer Screening Historic Market Size by Application (2021–2026)
5.2 Global Single Cancer Screening Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Single Cancer Screening Market Size (2021–2032)
6.2 North America Single Cancer Screening Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Single Cancer Screening Market Size by Country (2021–2026)
6.4 North America Single Cancer Screening Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Single Cancer Screening Market Size (2021–2032)
7.2 Europe Single Cancer Screening Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Single Cancer Screening Market Size by Country (2021–2026)
7.4 Europe Single Cancer Screening Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Single Cancer Screening Market Size (2021–2032)
8.2 Asia-Pacific Single Cancer Screening Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Single Cancer Screening Market Size by Region (2021–2026)
8.4 Asia-Pacific Single Cancer Screening Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Single Cancer Screening Market Size (2021–2032)
9.2 Latin America Single Cancer Screening Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Single Cancer Screening Market Size by Country (2021–2026)
9.4 Latin America Single Cancer Screening Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Single Cancer Screening Market Size (2021–2032)
10.2 Middle East & Africa Single Cancer Screening Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Single Cancer Screening Market Size by Country (2021–2026)
10.4 Middle East & Africa Single Cancer Screening Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Grail
11.1.1 Grail Company Details
11.1.2 Grail Business Overview
11.1.3 Grail Single Cancer Screening Introduction
11.1.4 Grail Revenue in Single Cancer Screening Business (2021–2026)
11.1.5 Grail Recent Development
11.2 Exact Sciences
11.2.1 Exact Sciences Company Details
11.2.2 Exact Sciences Business Overview
11.2.3 Exact Sciences Single Cancer Screening Introduction
11.2.4 Exact Sciences Revenue in Single Cancer Screening Business (2021–2026)
11.2.5 Exact Sciences Recent Development
11.3 Oncognostic
11.3.1 Oncognostic Company Details
11.3.2 Oncognostic Business Overview
11.3.3 Oncognostic Single Cancer Screening Introduction
11.3.4 Oncognostic Revenue in Single Cancer Screening Business (2021–2026)
11.3.5 Oncognostic Recent Development
11.4 Epigenomics
11.4.1 Epigenomics Company Details
11.4.2 Epigenomics Business Overview
11.4.3 Epigenomics Single Cancer Screening Introduction
11.4.4 Epigenomics Revenue in Single Cancer Screening Business (2021–2026)
11.4.5 Epigenomics Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Single Cancer Screening Introduction
11.5.4 Abbott Revenue in Single Cancer Screening Business (2021–2026)
11.5.5 Abbott Recent Development
11.6 Qiagen
11.6.1 Qiagen Company Details
11.6.2 Qiagen Business Overview
11.6.3 Qiagen Single Cancer Screening Introduction
11.6.4 Qiagen Revenue in Single Cancer Screening Business (2021–2026)
11.6.5 Qiagen Recent Development
11.7 iStat Biomedical
11.7.1 iStat Biomedical Company Details
11.7.2 iStat Biomedical Business Overview
11.7.3 iStat Biomedical Single Cancer Screening Introduction
11.7.4 iStat Biomedical Revenue in Single Cancer Screening Business (2021–2026)
11.7.5 iStat Biomedical Recent Development
11.8 Genetron Health
11.8.1 Genetron Health Company Details
11.8.2 Genetron Health Business Overview
11.8.3 Genetron Health Single Cancer Screening Introduction
11.8.4 Genetron Health Revenue in Single Cancer Screening Business (2021–2026)
11.8.5 Genetron Health Recent Development
11.9 New Horizon Health
11.9.1 New Horizon Health Company Details
11.9.2 New Horizon Health Business Overview
11.9.3 New Horizon Health Single Cancer Screening Introduction
11.9.4 New Horizon Health Revenue in Single Cancer Screening Business (2021–2026)
11.9.5 New Horizon Health Recent Development
11.10 Burning Rock
11.10.1 Burning Rock Company Details
11.10.2 Burning Rock Business Overview
11.10.3 Burning Rock Single Cancer Screening Introduction
11.10.4 Burning Rock Revenue in Single Cancer Screening Business (2021–2026)
11.10.5 Burning Rock Recent Development
11.11 Berry Oncology
11.11.1 Berry Oncology Company Details
11.11.2 Berry Oncology Business Overview
11.11.3 Berry Oncology Single Cancer Screening Introduction
11.11.4 Berry Oncology Revenue in Single Cancer Screening Business (2021–2026)
11.11.5 Berry Oncology Recent Development
11.12 Shanghai Kunyuan Biotechnology
11.12.1 Shanghai Kunyuan Biotechnology Company Details
11.12.2 Shanghai Kunyuan Biotechnology Business Overview
11.12.3 Shanghai Kunyuan Biotechnology Single Cancer Screening Introduction
11.12.4 Shanghai Kunyuan Biotechnology Revenue in Single Cancer Screening Business (2021–2026)
11.12.5 Shanghai Kunyuan Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Single Cancer Screening Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Colorectal Cancer
Table 3. Key Players of Liver Cancer
Table 4. Key Players of Lung Cancer
Table 5. Key Players of Other
Table 6. Global Single Cancer Screening Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Single Cancer Screening Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Single Cancer Screening Market Size by Region (US$ Million), 2021–2026
Table 9. Global Single Cancer Screening Market Share by Region (2021–2026)
Table 10. Global Single Cancer Screening Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global Single Cancer Screening Market Share by Region (2027–2032)
Table 12. Single Cancer Screening Market Trends
Table 13. Single Cancer Screening Market Drivers
Table 14. Single Cancer Screening Market Challenges
Table 15. Single Cancer Screening Market Restraints
Table 16. Global Single Cancer Screening Revenue by Players (US$ Million), 2021–2026
Table 17. Global Single Cancer Screening Market Share by Players (2021–2026)
Table 18. Global Top Single Cancer Screening Players by Tier (Tier 1, Tier 2, and Tier 3), based on Single Cancer Screening Revenue, 2025
Table 19. Ranking of Global Top Single Cancer Screening Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by Single Cancer Screening Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of Single Cancer Screening, Headquarters and Area Served
Table 22. Global Key Players of Single Cancer Screening, Products and Applications
Table 23. Global Key Players of Single Cancer Screening, Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global Single Cancer Screening Market Size by Type (US$ Million), 2021–2026
Table 26. Global Single Cancer Screening Revenue Market Share by Type (2021–2026)
Table 27. Global Single Cancer Screening Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global Single Cancer Screening Revenue Market Share by Type (2027–2032)
Table 29. Global Single Cancer Screening Market Size by Application (US$ Million), 2021–2026
Table 30. Global Single Cancer Screening Revenue Market Share by Application (2021–2026)
Table 31. Global Single Cancer Screening Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global Single Cancer Screening Revenue Market Share by Application (2027–2032)
Table 33. North America Single Cancer Screening Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America Single Cancer Screening Market Size by Country (US$ Million), 2021–2026
Table 35. North America Single Cancer Screening Market Size by Country (US$ Million), 2027–2032
Table 36. Europe Single Cancer Screening Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe Single Cancer Screening Market Size by Country (US$ Million), 2021–2026
Table 38. Europe Single Cancer Screening Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific Single Cancer Screening Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific Single Cancer Screening Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific Single Cancer Screening Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America Single Cancer Screening Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America Single Cancer Screening Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America Single Cancer Screening Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa Single Cancer Screening Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa Single Cancer Screening Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa Single Cancer Screening Market Size by Country (US$ Million), 2027–2032
Table 48. Grail Company Details
Table 49. Grail Business Overview
Table 50. Grail Single Cancer Screening Product
Table 51. Grail Revenue in Single Cancer Screening Business (US$ Million), 2021–2026
Table 52. Grail Recent Development
Table 53. Exact Sciences Company Details
Table 54. Exact Sciences Business Overview
Table 55. Exact Sciences Single Cancer Screening Product
Table 56. Exact Sciences Revenue in Single Cancer Screening Business (US$ Million), 2021–2026
Table 57. Exact Sciences Recent Development
Table 58. Oncognostic Company Details
Table 59. Oncognostic Business Overview
Table 60. Oncognostic Single Cancer Screening Product
Table 61. Oncognostic Revenue in Single Cancer Screening Business (US$ Million), 2021–2026
Table 62. Oncognostic Recent Development
Table 63. Epigenomics Company Details
Table 64. Epigenomics Business Overview
Table 65. Epigenomics Single Cancer Screening Product
Table 66. Epigenomics Revenue in Single Cancer Screening Business (US$ Million), 2021–2026
Table 67. Epigenomics Recent Development
Table 68. Abbott Company Details
Table 69. Abbott Business Overview
Table 70. Abbott Single Cancer Screening Product
Table 71. Abbott Revenue in Single Cancer Screening Business (US$ Million), 2021–2026
Table 72. Abbott Recent Development
Table 73. Qiagen Company Details
Table 74. Qiagen Business Overview
Table 75. Qiagen Single Cancer Screening Product
Table 76. Qiagen Revenue in Single Cancer Screening Business (US$ Million), 2021–2026
Table 77. Qiagen Recent Development
Table 78. iStat Biomedical Company Details
Table 79. iStat Biomedical Business Overview
Table 80. iStat Biomedical Single Cancer Screening Product
Table 81. iStat Biomedical Revenue in Single Cancer Screening Business (US$ Million), 2021–2026
Table 82. iStat Biomedical Recent Development
Table 83. Genetron Health Company Details
Table 84. Genetron Health Business Overview
Table 85. Genetron Health Single Cancer Screening Product
Table 86. Genetron Health Revenue in Single Cancer Screening Business (US$ Million), 2021–2026
Table 87. Genetron Health Recent Development
Table 88. New Horizon Health Company Details
Table 89. New Horizon Health Business Overview
Table 90. New Horizon Health Single Cancer Screening Product
Table 91. New Horizon Health Revenue in Single Cancer Screening Business (US$ Million), 2021–2026
Table 92. New Horizon Health Recent Development
Table 93. Burning Rock Company Details
Table 94. Burning Rock Business Overview
Table 95. Burning Rock Single Cancer Screening Product
Table 96. Burning Rock Revenue in Single Cancer Screening Business (US$ Million), 2021–2026
Table 97. Burning Rock Recent Development
Table 98. Berry Oncology Company Details
Table 99. Berry Oncology Business Overview
Table 100. Berry Oncology Single Cancer Screening Product
Table 101. Berry Oncology Revenue in Single Cancer Screening Business (US$ Million), 2021–2026
Table 102. Berry Oncology Recent Development
Table 103. Shanghai Kunyuan Biotechnology Company Details
Table 104. Shanghai Kunyuan Biotechnology Business Overview
Table 105. Shanghai Kunyuan Biotechnology Single Cancer Screening Product
Table 106. Shanghai Kunyuan Biotechnology Revenue in Single Cancer Screening Business (US$ Million), 2021–2026
Table 107. Shanghai Kunyuan Biotechnology Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Single Cancer Screening Picture
Figure 2. Global Single Cancer Screening Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Single Cancer Screening Market Share by Type: 2025 vs 2032
Figure 4. Colorectal Cancer Features
Figure 5. Liver Cancer Features
Figure 6. Lung Cancer Features
Figure 7. Other Features
Figure 8. Global Single Cancer Screening Market Size by Application (US$ Million), 2021–2032
Figure 9. Global Single Cancer Screening Market Share by Application: 2025 vs 2032
Figure 10. Hospital Case Studies
Figure 11. Physical Examination Center Case Studies
Figure 12. Other Case Studies
Figure 13. Single Cancer Screening Report Years Considered
Figure 14. Global Single Cancer Screening Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Single Cancer Screening Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Single Cancer Screening Market Share by Region: 2025 vs 2032
Figure 17. Global Single Cancer Screening Market Share by Players in 2025
Figure 18. Global Single Cancer Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Single Cancer Screening Revenue in 2025
Figure 20. North America Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Single Cancer Screening Market Share by Country (2021–2032)
Figure 22. United States Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Single Cancer Screening Market Share by Country (2021–2032)
Figure 26. Germany Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Single Cancer Screening Market Share by Region (2021–2032)
Figure 34. China Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Single Cancer Screening Market Share by Country (2021–2032)
Figure 42. Mexico Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Single Cancer Screening Market Share by Country (2021–2032)
Figure 46. Israel Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Single Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Grail Revenue Growth Rate in Single Cancer Screening Business (2021–2026)
Figure 50. Exact Sciences Revenue Growth Rate in Single Cancer Screening Business (2021–2026)
Figure 51. Oncognostic Revenue Growth Rate in Single Cancer Screening Business (2021–2026)
Figure 52. Epigenomics Revenue Growth Rate in Single Cancer Screening Business (2021–2026)
Figure 53. Abbott Revenue Growth Rate in Single Cancer Screening Business (2021–2026)
Figure 54. Qiagen Revenue Growth Rate in Single Cancer Screening Business (2021–2026)
Figure 55. iStat Biomedical Revenue Growth Rate in Single Cancer Screening Business (2021–2026)
Figure 56. Genetron Health Revenue Growth Rate in Single Cancer Screening Business (2021–2026)
Figure 57. New Horizon Health Revenue Growth Rate in Single Cancer Screening Business (2021–2026)
Figure 58. Burning Rock Revenue Growth Rate in Single Cancer Screening Business (2021–2026)
Figure 59. Berry Oncology Revenue Growth Rate in Single Cancer Screening Business (2021–2026)
Figure 60. Shanghai Kunyuan Biotechnology Revenue Growth Rate in Single Cancer Screening Business (2021–2026)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed